Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-16,197
Closed -$1.08M 1560
2021
Q2
$1.08M Sell
16,197
-934,011
-98% -$62.4M ﹤0.01% 989
2021
Q1
$70.7M Buy
950,208
+431,208
+83% +$32.7M 0.29% 74
2020
Q4
$37.8M Sell
519,000
-991,879
-66% -$70M 0.17% 148
2020
Q3
$100M Sell
1,510,879
-1,132,035
-43% -$71.7M 0.64% 29
2020
Q2
$151M Buy
2,642,914
+378,729
+17% +$18.6M 0.99% 15
2020
Q1
$79.5M Buy
2,264,185
+255,211
+13% +$12.2M 0.6% 44
2019
Q4
$105M Buy
2,008,974
+1,973,440
+5,554% +$98.3M 0.51% 54
2019
Q3
$1.79M Buy
+35,534
New +$1.75M 0.01% 567
2019
Q1
Sell
-89,567
Closed -$3.68M 1692
2018
Q4
$3.68M Buy
+89,567
New +$3.67M 0.04% 303
2018
Q3
Sell
-36,972
Closed -$1.47M 1102
2018
Q2
$1.47M Buy
+36,972
New +$1.42M 0.01% 843
2017
Q4
Sell
-598,228
Closed -$22.1M 1459
2017
Q3
$22.1M Buy
598,228
+564,528
+1,675% +$22.8M 0.14% 198
2017
Q2
$1.52M Buy
+33,700
New +$1.49M 0.01% 820

Other funds holding HOLX

Marshall Wace North America's HOLX Position: Q3 2021 in Review

Marshall Wace North America sold out of Hologic (HOLX) in Q3 2021, closing a stake of 16,197 shares — an estimated $1.08M sold.

Marshall Wace North America first reported a position in HOLX in Q2 2017 and held it in 12 quarters. The position peaked at $151M in Q2 2020. 644 funds tracked by Wall St. Rank hold HOLX as of Q3 2021.

  • Marshall Wace North America reported no remaining Hologic position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 16,197 Hologic shares in Q3 2021, an estimated $1.08M.
  • Marshall Wace North America first reported a position in Hologic in Q2 2017 and held it in 12 quarters.
  • Marshall Wace North America's Hologic position peaked at $151M in Q2 2020.
  • 644 funds tracked by Wall St. Rank held Hologic as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.